Abstract on the unique private-sector collaboration of the pharmaceutical companies GlaxoSmithKline (GSK) and Merck & Co., Inc., Kenilworth, N.J., U.S.A.,* to support the global efforts to
Abstract on the integration of mass drug administrations against multiple NTDs. Hopkins, Annals of Tropical Medicine & Parasitology, Volume 103, 2009 – Issue sup1.
Article on a symposium held to commemorate the 10th anniversary of the donation of Mectizan® and albendazole for the elimination of lymphatic filariasis. Hopkins
Abstract on the partnership launched in 1999 between the World Health Organization’s Programme for the Prevention of Blindness and Deafness and the International Agency
Abstract on the role of the World Bank in supporting the global partnership dedicated to the control of onchocerciasis. Bangoura, Annals of Tropical Medicine and
Abstract on the Onchocerciasis Elimination Program for the Americas (OEPA). Sauerbrey, Annals of Tropical Medicine and Parasitology, 2008 Sep; 102 Suppl 1:25-9. 2008.
Abstract on the establishment of the Onchocerciasis Control Programme in West Africa. Boatin, Annals of Tropical Medicine and Parasitology, 2008 Sep; 102 Suppl 1: 13-7.
Abstract on the involvement of the NGDO network in onchocerciasis control. Haddad, Annals of Tropical Medicine and Parasitology, 2008 Sep; 102 Suppl 1:35-8. 2008.
Abstract on the Mectizan® Donation Program (MDP), which was launched in 1987 by Merck & Co., Inc., Kenilworth, N.J., U.S.A.* Thylefors, Annals of Tropical Medicine and
Abstract on The African Programme for Onchocerciasis Control (APOC), which was launched in 1995 for the ultimate purpose of eliminating human onchocerciasis from the
Abstract on The Special Intervention Zones (SIZ) of the former Onchocerciasis Control Programme (OCP), which were launched in December 2002, following the closure of
Abstract on the efforts and progress of the African Programme for Onchocerciasis Control and the Onchocerciasis Elimination Program for the Americas against human onchocerciasis.
Article exploring economic impact of Mectizan distribution on affected communities. H. R. Waters, J. A. Rehwinkel, G. Burnham, First published: 13 April 2004.
Article addressing the creation of the methods and tools needed to deliver ivermectin and the evolution and development of distribution programmes. Burnham et al, Tropical Medicine
This evaluation examines how the Mectizan Donation Program (MDP) partnership has been functioning from the perspectives of partner organizations. Peters et al, Tropical Medicine and
Article discussing the impact of ivermectin on onchocerciasis, particularly through Merck & Co., Inc., Kenilworth, N.J., U.S.A.’s * establishment of the Mectizan® Distribution Program (MDP), which
Article reviewing the evolution of treatment strategies focused toward the goal of eliminating onchocerciasis as a public health problem. Thylefors, Tropical Medicine and International Health,
